[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356414-105":59,"doc-detail-356414-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","transitioning-from-cytology-to-hpv-test-based-primary-cervical-screening-in-canada-a-population-based-survey-of-womens-screening-and-information-preferences","Transitioning from Cytology to HPV Test-Based Primary Cervical Screening in Canada - A Population-Based Survey of Women’s Screening and Information Preferences","","Canada’s cervical cancer elimination plan faces low screening participation and growing incidence despite Pap-test screening. Cytology is being replaced by HPV testing, expected to detect pre-cancer more sensitively and enable later start ages and longer intervals, yet knowledge gaps and negative attitudes hinder uptake. A web-based national survey using Best–Worst Scaling quantified women’s preferences for test modality, initiation age, intervals, information sources, provider type, and communication methods. Women favored co-testing, starting at 21, three-year intervals, email communication, and—especially when underscreened—HPV self-sampling and gynecologist provision.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/transitioning-from-cytology-to-hpv-test-based-primary-cervical-screening-in-canada-a-population-based-survey-of-womens-screening-and-information-preferences/356414/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/transitioning-from-cytology-to-hpv-test-based-primary-cervical-screening-in-canada-a-population-based-survey-of-womens-screening-and-information-preferences/356414.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is Canada transitioning from cytology to HPV test-based primary cervical screening?","Question",{"text":113,"@type":114},"The transition is driven by the expectation that HPV testing detects pre-cancer more sensitively and can support initiating screening later and extending screening intervals, while addressing challenges to cervical cancer elimination.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What screening preferences did women report in the national survey?",{"text":118,"@type":114},"Women preferred HPV testing in conjunction with Pap testing (co-testing), starting screening at age 21, and maintaining screening intervals every three years.",{"name":120,"@type":111,"acceptedAnswer":121},"How did communication preferences differ between groups and what channels were favored?",{"text":122,"@type":114},"Across groups, participants preferred receiving screening information by email rather than postal mail, and underscreened individuals showed relatively higher preference for HPV self-sampling and gynecologist provision.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},356414,1790163850,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nTransitioning from Cytology to HPV Test-Based Primary Cervical Screening in Canada: A Population-Based Survey of Women’s Screening and Information Preferences  \nOvidiu Tatar 1,2,3, *,†, Patricia Zhu 1,†, Shannon Salvador 4, Susie Lau 4, Jessica Ruel-Laliberté 5, Samara Perez 6,7,8, Emily McBride 9 and Zeev Rosberger 1,3,6,10, *  \nReceived: 29 November 2025  \nRevised: 24 January 2026  \nAccepted: 28 January 2026  \nPublished: 4 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC H3T 1E1, Canada; [yue.y.zhu@mail.mcgill.ca](yue.y.zhu@mail.mcgill.ca)  \n2 Douglas Hospital Research Center, Montreal, QC H4H 1R3, Canada  \n3 Department of Psychiatry, McGill University, Montreal, QC H3A 1A1, Canada  \n4 Division of Gynecologic Oncology, Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada; [shannon.salvador@mcgill.ca](shannon.salvador@mcgill.ca) (S.S.); [susie.lau@mcgill.ca](susie.lau@mcgill.ca) (S.L.)  \n5 Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada; jessica.ruel-laliberte@usherbrooke.ca  \n6 Department of Oncology, McGill University, Montreal, QC H4A 3T2, Canada; [samara.perez@mcgill.ca](samara.perez@mcgill.ca)  \n7 Research Institute of McGill University Health Centre, Montréal, QC H3H 2R9, Canada  \n8 Psychosocial Oncology Program, Division of Supportive & Palliative Care, Cedars Cancer Centre, McGill University Health Centre, Montréal, QC H4A 3J1, Canada  \n9 Institute of Psychology, Psychiatry and Neuroscience, King’s College London, London SE5 8AF, UK; [emily.mcbride@kcl.ac.uk](emily.mcbride@kcl.ac.uk)  \n10 Department of Psychology, McGill University, Montreal, QC H3A 1G1, Canada  \n* Correspondence: [ovidiu.tatar@mail.mcgill.ca](ovidiu.tatar@mail.mcgill.ca) (O.T.); [zeev.rosberger@mcgill.ca](zeev.rosberger@mcgill.ca) (Z.R.)† These authors contributed equally to this work.  \nSimple Summary  \nIn Canada, the Pap test (cytology), used for decades for cervical screening, is being replaced by human papillomavirus (HPV) testing, which can detect pre-cancer more sensitively and allows longer screening intervals. To support this transition, we conducted a national survey to understand women’s preferences for screening methods, starting age, screening intervals, and how screening information should be communicated. We found that women prefer using the HPV test in conjunction with the Pap test, starting screening at age 21, and maintaining screening intervals every three years. They also prefer receiving information by email rather than by postal mail. Women who do not participate regularly in screening showed high preferences for self-sampling and preferred receiving the HPV test from a gynecologist rather than a family physician. Successful implementation of the new screening test requires tailored information and empowering women to use self-sampling to support optimal uptake and progress toward cervical cancer elimination in Canada.  \nAbstract  \nBackground: Canada’s cervical cancer elimination plan is challenged by suboptimal screening participation and rising incidence of cervical cancer over the past decade. Cytology, the primary cervical screening method in Canada, is being replaced with HPV testing, which offers superior sensitivity for detecting pre-cancerous lesions and supports initiating screening at age 25 or older and extending screening intervals to five years. Research has shown that women’s insufficient knowledge and negative attitudes toward HPV screening represent a significant barrier to screening uptake. Methods: We conducted a web-based national survey using Best–Worst Scaling (trade off utilities) to quantify women’s preferences for screening te","cbCaieGLV7UW42gU","https://ap.wps.com/l/cbCaieGLV7UW42gU","pdf",766782,27,"English","# Introduction\n# Simple Summary\n# Abstract\n# Keywords","[{\"question\":\"Why is Canada transitioning from cytology to HPV test-based primary cervical screening?\",\"answer\":\"The transition is driven by the expectation that HPV testing detects pre-cancer more sensitively and can support initiating screening later and extending screening intervals, while addressing challenges to cervical cancer elimination.\"},{\"question\":\"What screening preferences did women report in the national survey?\",\"answer\":\"Women preferred HPV testing in conjunction with Pap testing (co-testing), starting screening at age 21, and maintaining screening intervals every three years.\"},{\"question\":\"How did communication preferences differ between groups and what channels were favored?\",\"answer\":\"Across groups, participants preferred receiving screening information by email rather than postal mail, and underscreened individuals showed relatively higher preference for HPV self-sampling and gynecologist provision.\"}]","Transitioning from Cytology to HPV Test-Based Primary Cervical Screening in Canada - A Population-Based Survey of Women’s Screening and Information Preferences | PDF",1790125261,68,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/15ae404ddd70b11c283fd96872a7ad63.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5c3187a78d6aa3ea91d9dd2463e5db0.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c984718945b963c9d8660e625c82e1d.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7984a0ece5d73afb8455bc12c93ba061.webp",980,1385]